MedPath

Accelerated Tooth Movement With AcceleDent® and Aligners - a Pilot Project

Not Applicable
Completed
Conditions
Tooth Movement
Malocclusion
Interventions
Device: AcceleDent, Vibrational Device
Registration Number
NCT02438280
Lead Sponsor
University of Washington
Brief Summary

The AcceleDent® device has been introduced to the specialty of orthodontics in order to reduce treatment time. The theory behind AcceleDent® is that high frequency vibratory forces (30Hz) delivered to the teeth will stimulate the bone remodeling that is necessary for tooth movement to occur more quickly.

Additionally, one claim of the AcceleDent® product is that it may reduce pain and discomfort during orthodontic treatment.

This study will be a parallel group, triple-blind randomized clinical trial comparing two groups of subjects with 12 participants in each group. Subjects will be randomized to receive one of two vibrational units, which will differ in frequency and/or amplitude of vibration. The subjects will be asked to change their aligners every week instead of every 2 weeks, which is common with Invisalign.

Detailed Description

This study will be a parallel group, triple-blind randomized clinical trial comparing two groups of subjects with 12 participants in each group. Subjects will be randomized to receive one of two vibrational units, which will differ in frequency and/or amplitude of vibration. The subjects will be asked to change their aligners every week instead of every 2 weeks, which is common with Invisalign.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
27
Inclusion Criteria
  1. Patients with malocclusions that require minor or no anterior-posterior or transverse correction in the posterior teeth, and are planned for <= 25 aligners to complete treatment.
  2. Treatment must be dual arch in order for patients to qualify for this study.
  3. Patients must be 18 years or older
Exclusion Criteria
  1. Patients with systematic diseases or syndromes
  2. Patients with a history or current use of Bisphosphonates
  3. Patients with current use of nonsteroidal anti-inflammatory drugs (NSAIDs)prostaglandin inhibitors.
  4. Patients with generalized moderate to severe periodontitis
  5. Patients with active oral hard tissue or soft tissue lesions
  6. Patients with chronic oral and maxillofacial conditions such as trigeminal neuralgia, temporomandibular disorder and orofacial pain.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham VibrationAcceleDent, Vibrational DeviceUse of Sham Vibration (Sham AcceleDent device) 20 minutes each day during treatment with aligners
Active VibrationAcceleDent, Vibrational DeviceUse of Active Vibration (AcceleDent device) 20 minutes each day during treatment with aligners
Primary Outcome Measures
NameTimeMethod
Ability to Complete Treatment Aligners in Conjunction With an Active and Placebo Vibration Device (AcceleDent® Aura)6 months

The outcome was the ability to complete the initial set of aligners using either an active vibration device or a placebo vibration device. Regardless of the group assignment, patients were asked to change their aligners each week, and we tracked the percentage that were able to complete their series of aligners.

Secondary Outcome Measures
NameTimeMethod
Final Alignment Scores of the Upper and Lower Incisors6 months

Final alignment was measured using Little's incisor irregularity index. This index sums the displacement of the contact points of the anterior teeth, to produce a millimetric number. The lower the score, the more perfect the alignment.

Trial Locations

Locations (2)

Cohanim Smileworks

🇺🇸

Seattle, Washington, United States

Dr. Sandra Tai

🇨🇦

Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath